Entera Bio Ltd.
ENTX | NASDAQ
$2.99
+$0.03 (+1.01%)
Sep 22, 2026, 2:21 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | -11.44M | -9.54M | -8.89M | -13.07M | -12.19M | -11.22M |
Depreciation & Amortization | 30K | 46K | 56K | 64K | 53K | 63K |
Stock-Based Compensation | 2.75M | 2.56M | 1.69M | 2.25M | 1.86M | 901K |
Other Working Capital | 815K | 189K | -507K | -1.62M | 1.34M | -227K |
Other Non-Cash Items | 32K | -5K | 1.69M | -78K | 18K | 46K |
Deferred Income Tax | n/a | 14K | 29K | 174K | -217K | n/a |
Change in Working Capital | 1.26M | 112K | -195K | -1.84M | 1.41M | -351K |
Operating Cash Flow | -7.37M | -6.82M | -7.31M | -12.5M | -9.06M | -10.56M |
Capital Expenditures | -107K | -3K | -17K | -47K | -17K | -53K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -55K | n/a | n/a |
Investing Cash Flow | -107K | -3K | -17K | -102K | -17K | -53K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | -136K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 516K | -580K | n/a | 3.58M | 204K |
Financial Cash Flow | 13.71M | 4.48M | 6.04M | 13K | 25.38M | 4.05M |
Net Cash Flow | 6.23M | -2.35M | -1.29M | -12.58M | 16.3M | -6.56M |
Free Cash Flow | -7.48M | -6.82M | -7.33M | -12.55M | -9.08M | -10.61M |
Adj. Free Cash Flow | -10.23M | -9.38M | -9.02M | -14.79M | -10.94M | -11.51M |
Maintenance CapEx | -107K | n/a | -17K | -47K | n/a | n/a |
Growth CapEx | n/a | -3K | n/a | n/a | -17K | -53K |
Owner Earnings | -7.48M | -6.82M | -7.33M | -12.55M | -9.06M | -10.56M |
Add to Watchlist
Select watchlists to add or remove ENTX